1/20/2022CDE Issues the Technical Guidance on Clinical Protocol for Injectable ...

1/19/2022NMPA Solicits Comments on the Draft of GMP's Clinical Trial Drug Appen...

1/19/2022NHSA Holds National Healthcare Security Conference, Highlighting Polic...

1/19/2022Anti-tumor Drugs Became the Hottest Treatments in December (PharmaDJ's...

1/18/2022NMPA Issues Two Registration Review Guidelines for Drug-Device Combina...

1/18/2022Mabwell's IPO Debuts on SSE STAR Market, Shares Plunging 27%

1/18/2022Review of Chinese Pharmaceutical industry Performance Q1/2019-Q3/2021

1/17/2022What FDA Crackdown? Novartis Oncology Chief Touts BeiGene PD-1's Globa...

1/17/2022China NMPA Novel Drug Approvals 2021 (PharmCube)

1/17/2022Licensing Moves Towards Early-Stage Assets in 2021: PharmaDJ

1/17/2022Massive Series A Rounds in December 2021 Highlight New R&D Trends: Pha...

1/14/2022Recent Executive Moves

1/14/2022NMPA Announces Package Insert Revision of Cimetidine Injectable Formul...

1/13/2022FUJIFILM Irvine Scientific Plans Bioprocessing Center in China

1/11/2022Reuters: Biotech Is Set for a Geopolitical Stress Test

1/11/2022China Healthcare Stocks Post Worst Start in Six Years as Woes Deepen (...

1/11/2022China Solidifies Drug-Buying Programme That Saved $55 Billion

1/9/20222021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ

1/7/2022Nuance Pharma Acquires Sino Health to Strengthen Commercial Capabiliti...

1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...

1/7/2022NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China

1/7/2022Recent Executive Moves

1/6/2022NMPA Solicits Comments on the Draft of GMP's Cell Therapy Product Appe...

1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...

1/5/2022Junshi Biosciences Terminates Promotion Agreement with Astrazeneca

1/5/20223SBio's Sunshine Guojian and Syncromune Enter Co-development Deal for ...

1/5/2022Review of Sino-Foreign Drug Out-licensing Deals in 2021

1/5/2022Review of Chinese Pharma In-licensing Deals in 2021

1/5/2022SMEI: Chinese Urban Chemical Drug Hospital Market Rebounded 10% in 3Qs...

1/5/2022China 2021: The NRDL Readout (PharmExec)

Page:50/333 Total number of articles:9989: [First][<<] [48] [49] [50] [51] [52] [>>] [End]